advertisement

Topcon

Li X 20

Showing records 1 to 20 | Display all abstracts from Li X

70396 Optic cup segmentation from fundus images for glaucoma diagnosis
Hu M
Bioengineered 2017; 8: 21-28
69833 Corneal Haze as Prognostic Indicator of Intraocular Pressure in Primary Congenital Glaucoma
Li X
Journal of Glaucoma 2016; 25: e855-e860
70116 Anti-VEGF treatment is the key strategy for neovascular glaucoma management in the short term
Sun Y
BMC Ophthalmology 2016; 16: 150
69777 Venous thromboembolism does not share familial susceptibility with retinal vascular occlusion or glaucoma: a nationwide family study
Zöller B
Journal of thrombosis and thrombolysis 2016; 42: 505-512
69833 Corneal Haze as Prognostic Indicator of Intraocular Pressure in Primary Congenital Glaucoma
Mukkamala L
Journal of Glaucoma 2016; 25: e855-e860
70396 Optic cup segmentation from fundus images for glaucoma diagnosis
Zhu C
Bioengineered 2017; 8: 21-28
70116 Anti-VEGF treatment is the key strategy for neovascular glaucoma management in the short term
Liang Y
BMC Ophthalmology 2016; 16: 150
69777 Venous thromboembolism does not share familial susceptibility with retinal vascular occlusion or glaucoma: a nationwide family study
Li X
Journal of thrombosis and thrombolysis 2016; 42: 505-512
69833 Corneal Haze as Prognostic Indicator of Intraocular Pressure in Primary Congenital Glaucoma
Origlieri CA
Journal of Glaucoma 2016; 25: e855-e860
70396 Optic cup segmentation from fundus images for glaucoma diagnosis
Li X
Bioengineered 2017; 8: 21-28
70116 Anti-VEGF treatment is the key strategy for neovascular glaucoma management in the short term
Zhou P
BMC Ophthalmology 2016; 16: 150
69777 Venous thromboembolism does not share familial susceptibility with retinal vascular occlusion or glaucoma: a nationwide family study
Sundquist J
Journal of thrombosis and thrombolysis 2016; 42: 505-512
70116 Anti-VEGF treatment is the key strategy for neovascular glaucoma management in the short term
Wu H
BMC Ophthalmology 2016; 16: 150
69777 Venous thromboembolism does not share familial susceptibility with retinal vascular occlusion or glaucoma: a nationwide family study
Sundquist K
Journal of thrombosis and thrombolysis 2016; 42: 505-512
69833 Corneal Haze as Prognostic Indicator of Intraocular Pressure in Primary Congenital Glaucoma
Holland BK
Journal of Glaucoma 2016; 25: e855-e860
70396 Optic cup segmentation from fundus images for glaucoma diagnosis
Xu Y
Bioengineered 2017; 8: 21-28
69833 Corneal Haze as Prognostic Indicator of Intraocular Pressure in Primary Congenital Glaucoma
Fechtner RD
Journal of Glaucoma 2016; 25: e855-e860
70116 Anti-VEGF treatment is the key strategy for neovascular glaucoma management in the short term
Hou X; Ren Z
BMC Ophthalmology 2016; 16: 150
69833 Corneal Haze as Prognostic Indicator of Intraocular Pressure in Primary Congenital Glaucoma
Khouri AS
Journal of Glaucoma 2016; 25: e855-e860
70116 Anti-VEGF treatment is the key strategy for neovascular glaucoma management in the short term
Li X; Zhao M
BMC Ophthalmology 2016; 16: 150

Issue 18-2

Change Issue


advertisement

Oculus